|
Psychedelic Q&A with Rick Doblin |
|
|
This Q&A session covers a wide range of psychedelic related topics, including MAPS, psychedelic-assisted therapy, the balance between medicalization and legalization, the FDA approval process for MDMA-assisted therapy, global expansion efforts, challenges in obtaining European approvals, and the evolving landscape of psychedelics.
Date:
Wednesday, October 4, 2023
|
|
|||||||||||||||||